Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease

European Journal of Medicinal Chemistry
2019.0

Abstract

Facing the complexity of Alzheimer's disease (AD), it is now currently admitted that a therapeutic pleiotropic intervention is needed to alter its progression. Among the major hallmarks of the disease, the amyloid pathology and the oxidative stress are closely related. We propose in this study to develop original Multi-Target Directed Ligands (MTDL) able to impact at the same time Aβ protein accumulation and toxicity of Reactive Oxygen Species (ROS) in neuronal cells. Such MTDL were obtained by linking on a central piperidine two scaffolds of interest: a typical aminochlorobenzophenone present in numerous 5-HT<sub>4</sub>R agonists, and diverse antioxidant chemotypes. Interestingly, the most active compound 9g possesses a Ki of 12.7 nM towards 5-HT<sub>4</sub>R and an antioxidant activity in vitro and in cellulo.

Knowledge Graph

Similar Paper

Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease
European Journal of Medicinal Chemistry 2019.0
Synthesis of dual AChE/5-HT4 receptor multi-target directed ligands
MedChemComm 2012.0
Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease
Journal of Medicinal Chemistry 2007.0
Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT<sub>4</sub>R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride
Journal of Medicinal Chemistry 2015.0
Discovery of effective phosphodiesterase 2 inhibitors with antioxidant activities for the treatment of Alzheimer’s disease
Bioorganic &amp; Medicinal Chemistry Letters 2021.0
Design, synthesis and biological evaluation of 2-styryl-5-hydroxy-4-pyrone derivatives and analogues as multiple functional agents with the potential for the treatment of Alzheimer’s disease
Bioorganic &amp; Medicinal Chemistry 2021.0
Inhibition of Acetylcholinesterase, β-Amyloid Aggregation, and NMDA Receptors in Alzheimer’s Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush
Journal of Medicinal Chemistry 2008.0
Multitarget-Directed Benzylideneindanone Derivatives: Anti-β-Amyloid (Aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties against Alzheimer’s Disease
Journal of Medicinal Chemistry 2012.0
Design, Synthesis, and Biological Evaluation of New 5-HT<sub>4</sub> Receptor Agonists: Application as Amyloid Cascade Modulators and Potential Therapeutic Utility in Alzheimer’s Disease
Journal of Medicinal Chemistry 2009.0
Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer’s disease
Bioorganic &amp; Medicinal Chemistry 2017.0